首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Anti-diabetic and anti-obesitic effects of aqueous extracts of Yangkyuksanhwa-tang and its two major compositions on db/db mice
【24h】

Anti-diabetic and anti-obesitic effects of aqueous extracts of Yangkyuksanhwa-tang and its two major compositions on db/db mice

机译:羊草散及其两种主要成分的水提取物对db / db小鼠的抗糖尿病和抗肥胖作用

获取原文
获取原文并翻译 | 示例
           

摘要

Type 2 diabetes mellitus (T2DM) is a metabolic syndrome that results from target-tissue resistance to insulin. Obesity is the condition of excess body fat accumulation. T2DM and obesity are both associated with hypertension, hyperlipidemia, and abdominal obesity. In Korean medicine, Yangkyuksanhwa-tang (YKSHT) has been prescribed for patients with T2DM. Oral glucose tolerance tests (OGTT), multiplex assays and hemoglobin A(1C) (HbA1C) assessments were performed to determine the anti-diabetic effects of YKSHT and two major compositions of YKSHT, Lonicera japonica Thunb. (LJT) and Rehmannia glutinosa (RG) on db/db mice, a rodent model for T2DM. To study the anti-obesitic effects of LJT, RG or YKSHT, blood profiling including the triglycerides (TGs) and the total, LDL and HDL cholesterol levels were measured. In addition, body index measures such as the liver, retroperitoneal and epididymal fat tissues were collected and weighed. Mice treated with RG or YKSHT showed reduced blood glucose levels after stimulating the plasma GLP-1 levels. The multiplex assay results support the weight-controlling effects of the LJT, RG and YKSHT treatments, showing reducing levels of ghrelin and the induction of peptide YY (PYY) secretion. The YKSHT treatment reduced plasma TG levels and increased HDL cholesterol levels. The weights of the liver, retroperitoneal and epididymal fat tissues were reduced after the YKSHT treatment. Hence, we suggest that YKSHTcan be utilized for the prevention and treatment of T2DM and obesity simultaneously. (C) 2016 Elsevier Masson SAS. All rights reserved.
机译:2型糖尿病(T2DM)是一种代谢综合征,由靶组织对胰岛素的抵抗力引起。肥胖是体内多余脂肪堆积的条件。 T2DM和肥胖都与高血压,高脂血症和腹部肥胖有关。在韩国医学中,已对患有T2DM的患者开了Yangkyuksanhwa-tang(YKSHT)处方。进行了口服葡萄糖耐量测试(OGTT),多重分析和血红蛋白A(1C)(HbA1C)评估,以确定YKSHT和YKSHT的两种主要成分忍冬属忍冬的抗糖尿病作用。 (LJT)和地黄(RG)在db / db小鼠上,这是T2DM的啮齿动物模型。为了研究LJT,RG或YKSHT的抗肥胖作用,测量了包括甘油三酸酯(TGs)以及总胆固醇,LDL和HDL胆固醇水平的血液概况。另外,收集并称重身体指标指标,例如肝脏,腹膜后和附睾脂肪组织。 RG或YKSHT处理的小鼠在刺激血浆GLP-1水平后显示血糖水平降低。多重测定结果支持LJT,RG和YKSHT治疗的体重控制效果,显示出生长素释放肽水平降低和诱导肽YY(PYY)分泌。 YKSHT治疗降低血浆TG水平并增加HDL胆固醇水平。 YKSHT治疗后,肝脏,腹膜后和附睾脂肪组织的重量减少。因此,我们建议YKSHT可以同时用于预防和治疗T2DM和肥胖。 (C)2016 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号